Brendan Kyne CYTC Cor CYTC-Q TOP PICK Nov 16, 2000

Brendan Kyne

Unknown

Unlock Rating

$54.000

Stock price when the opinion was issued

biotechnology pharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

TOP PICK

Expensive, but very good profit growth.

TOP PICK

A good system for detection of cervical cancer (compared to pap smears) and are working on breast cancer now. Growing substantially.

PAST TOP PICK

(Was a top pick on Oct 4 down 25%)

Most Recent Experts

Keith Richards

ValueTrend Wealth Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Teal Linde

Linde Equity Report

Stockchase Insights

5i Research

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Brendan Kyne CYTC Cor CYTC-Q TOP PICK Nov 16, 2000

You might be interested:

CYTC Cor(CYTC-Q)

CYTC Cor(CYTC-Q)

CYTC Cor(CYTC-Q)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Keith Richards

The Panic-Proof Portfolio (Stockchase Research)

Larry Berman CFA, CMT, CTA

Teal Linde

Stockchase Insights